The foamy virus gag proteins: What makes them different?

Viruses

Volumn 5, Issue 4, 2013, Pages 1023-1041

  Müllers, Erik ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Foamy Virus Gag; Functional domains; GR box; Nuclear localization; Virus assembly

Indexed keywords

ARGININE; CELL PROTEIN; GAG PROTEIN; GLYCINE; VIRUS ENVELOPE PROTEIN;

CELL NUCLEUS; GENE EXPRESSION REGULATION; HOST CELL; INTRACELLULAR TRANSPORT; NUCLEOTIDE SEQUENCE; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN MOTIF; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTEIN TRANSPORT; RETROVIRUS; REVIEW; SEQUENCE HOMOLOGY; SPUMA VIRUS; VIRUS ASSEMBLY; VIRUS GENE; VIRUS RELEASE; VIRUS REPLICATION;

ANIMALS; GENE PRODUCTS, GAG; HOST-PATHOGEN INTERACTIONS; HUMANS; PROTEIN BINDING; PROTEIN INTERACTION DOMAINS AND MOTIFS; SPUMAVIRUS; VIRUS REPLICATION;

HUMAN SPUMARETROVIRUS;

EID: 84875694561     PISSN: 19994915     EISSN: None     Source Type: Journal    
DOI: 10.3390/v5041023     Document Type: Review

References (99)

1. Freed, E.O. Hiv-1 gag proteins: Diverse functions in the virus life cycle. Virology 1998, 251, 1-15.
2. Meiering, C.D.; Linial, M.L. Historical perspective of foamy virus epidemiology and infection. Clin. Microbiol. Rev. 2001, 14, 165-176.
3. Saib, A. Non-primate foamy viruses. Curr. Top. Microbiol. Immunol. 2003, 277, 197-211.
4. Linial, M.L. Foamy viruses are unconventional retroviruses. J. Virol. 1999, 73, 1747-1755.
5. Rethwilm, A. Foamy virus vectors: An awaited alternative to gammaretro-and lentiviral vectors. Curr. Gene Ther. 2007, 7, 261-271.
6. Bruss, V. Hepatitis b virus morphogenesis. World J. Gastroenterol. 2007, 13, 65-73.
7. Achong, B.G.; Mansell, P.W.; Epstein, M.A.; Clifford, P. An unusual virus in cultures from a human nasopharyngeal carcinoma. J. Natl. Cancer Inst. 1971, 46, 299-307.
8. Herchenroder, O.; Renne, R.; Loncar, D.; Cobb, E.K.; Murthy, K.K.; Schneider, J.; Mergia, A.; Luciw, P.A. Isolation, cloning, and sequencing of simian foamy viruses from chimpanzees (sfvcpz): High homology to human foamy virus (hfv). Virology 1994, 201, 187-199.
9. Schweizer, M.; Turek, R.; Hahn, H.; Schliephake, A.; Netzer, K.O.; Eder, G.; Reinhardt, M.; Rethwilm, A.; Neumann-Haefelin, D. Markers of foamy virus infections in monkeys, apes, and accidentally infected humans: Appropriate testing fails to confirm suspected foamy virus prevalence in humans. AIDS Res. Hum. Retroviruses 1995, 11, 161-170.
10. Enssle, J.; Jordan, I.; Mauer, B.; Rethwilm, A. Foamy virus reverse transcriptase is expressed independently from the gag protein. Proc. Natl. Acad. Sci. U. S. A. 1996, 93, 4137-4141.
11. Lochelt, M.; Flugel, R.M. The human foamy virus pol gene is expressed as a pro-pol polyprotein and not as a gag-pol fusion protein. J. Virol. 1996, 70, 1033-1040.
12. Yu, S.F.; Baldwin, D.N.; Gwynn, S.R.; Yendapalli, S.; Linial, M.L. Human foamy virus replication: A pathway distinct from that of retroviruses and hepadnaviruses. Science 1996, 271, 1579-1582.
13. Giron, M.L.; Colas, S.; Wybier, J.; Rozain, F.; Emanoil-Ravier, R. Expression and maturation of human foamy virus gag precursor polypeptides. J. Virol. 1997, 71, 1635-1639.
14. Pfrepper, K.I.; Lochelt, M.; Rackwitz, H.R.; Schnolzer, M.; Heid, H.; Flugel, R.M. Molecular characterization of proteolytic processing of the gag proteins of human spumavirus. J. Virol. 1999, 73, 7907-7911.
15. Enssle, J.; Fischer, N.; Moebes, A.; Mauer, B.; Smola, U.; Rethwilm, A. Carboxy-terminal cleavage of the human foamy virus gag precursor molecule is an essential step in the viral life cycle. J. Virol. 1997, 71, 7312-7317.
16. Zemba, M.; Wilk, T.; Rutten, T.; Wagner, A.; Flugel, R.M.; Lochelt, M. The carboxy-terminal p3gag domain of the human foamy virus gag precursor is required for efficient virus infectivity. Virology 1998, 247, 7-13.
17. Konvalinka, J.; Lochelt, M.; Zentgraf, H.; Flugel, R.M.; Krausslich, H.G. Active foamy virus proteinase is essential for virus infectivity but not for formation of a pol polyprotein. J. Virol. 1995, 69, 7264-7268.
18. Cartellieri, M.; Herchenroder, O.; Rudolph, W.; Heinkelein, M.; Lindemann, D.; Zentgraf, H.; Rethwilm, A. N-terminal gag domain required for foamy virus particle assembly and export. J. Virol. 2005, 79, 12464-12476.
19. Wang, J.; Guo, H.Y.; Jia, R.; Xu, X.; Tan, J.; Geng, Y.Q.; Qiao, W.T. Preparation of bfv gag antiserum and preliminary study on cellular distribution of bfv. Virol. Sin. 2010, 25, 115-122.
20. Lehmann-Che, J.; Renault, N.; Giron, M.L.; Roingeard, P.; Clave, E.; Tobaly-Tapiero, J.; Bittoun, P.; Toubert, A.; de The, H.; Saib, A. Centrosomal latency of incoming foamy viruses in resting cells. PLoS Pathog. 2007, 3, e74.
21. Hutter, S.; Mullers, E.; Stanke, N.; Reh, J.; Lindemann, D. Prototype foamy virus protease activity is essential for intra-particle reverse transcription initiation but not absolutely required for uncoating upon host cell entry. J. Virol. 2013.
22. Lindemann, D.; Rethwilm, A. Foamy virus biology and its application for vector development. Viruses 2011, 3, 561-585.
23. Swanstrom, R.; Wills, J.W. Synthesis, assembly, and processing of viral proteins. In Retroviruses, Coffin, J.M.; Hughes, S.H., Varmus, H.E. Eds. Cold Spring Harbor (NY), 1997.
24. Geiselhart, V.; Schwantes, A.; Bastone, P.; Frech, M.; Lochelt, M. Features of the env leader protein and the n-terminal gag domain of feline foamy virus important for virus morphogenesis. Virology 2003, 310, 235-244.
25. Life, R.B.; Lee, E.G.; Eastman, S.W.; Linial, M.L. Mutations in the amino terminus of foamy virus gag disrupt morphology and infectivity but do not target assembly. J. Virol. 2008, 82, 6109-6119.
26. Wilk, T.; Geiselhart, V.; Frech, M.; Fuller, S.D.; Flugel, R.M.; Lochelt, M. Specific interaction of a novel foamy virus env leader protein with the n-terminal gag domain. J. Virol. 2001, 75, 7995-8007.
27. Pietschmann, T.; Heinkelein, M.; Heldmann, M.; Zentgraf, H.; Rethwilm, A.; Lindemann, D. Foamy virus capsids require the cognate envelope protein for particle export. J. Virol. 1999, 73, 2613-2621.
28. Lindemann, D.; Pietschmann, T.; Picard-Maureau, M.; Berg, A.; Heinkelein, M.; Thurow, J.; Knaus, P.; Zentgraf, H.; Rethwilm, A. A particle-associated glycoprotein signal peptide essential for virus maturation and infectivity. 2001, 75, 5762-5771.
29. Sfakianos, J.N.; Hunter, E. M-pmv capsid transport is mediated by env/gag interactions at the pericentriolar recycling endosome. Traffic 2003, 4, 671-680.
30. Yu, S.F.; Eastman, S.W.; Linial, M.L. Foamy virus capsid assembly occurs at a pericentriolar region through a cytoplasmic targeting/retention signal in gag. Traffic 2006, 7, 966-977.
31. Linial, M.L.; Eastman, S.W. Particle assembly and genome packaging. Curr. Top. Microbiol. Immunol. 2003, 277, 89-110.
32. Eastman, S.W.; Linial, M.L. Identification of a conserved residue of foamy virus gag required for intracellular capsid assembly. J. Virol. 2001, 75, 6857-6864.
33. Choi, G.; Park, S.; Choi, B.; Hong, S.; Lee, J.; Hunter, E.; Rhee, S.S. Identification of a cytoplasmic targeting/retention signal in a retroviral gag polyprotein. J. Virol. 1999, 73, 5431-5437.
34. Craven, R.C.; Parent, L.J. Dynamic interactions of the gag polyprotein. Curr. Top. Microbiol. Immunol. 1996, 214, 65-94.
35. Tobaly-Tapiero, J.; Bittoun, P.; Giron, M.L.; Neves, M.; Koken, M.; Saib, A.; de The, H. Human foamy virus capsid formation requires an interaction domain in the n terminus of gag. J. Virol. 2001, 75, 4367-4375.
36. Bowzard, J.B.; Bennett, R.P.; Krishna, N.K.; Ernst, S.M.; Rein, A.; Wills, J.W. Importance of basic residues in the nucleocapsid sequence for retrovirus gag assembly and complementation rescue. J. Virol. 1998, 72, 9034-9044.
37. Mannigel, I.; Stange, A.; Zentgraf, H.; Lindemann, D. Correct capsid assembly mediated by a conserved yxxlgl motif in prototype foamy virus gag is essential for infectivity and reverse transcription of the viral genome. J. Virol. 2007, 81, 3317-3326.
38. Mullers, E.; Uhlig, T.; Stirnnagel, K.; Fiebig, U.; Zentgraf, H.; Lindemann, D. Novel functions of prototype foamy virus gag glycine-arginine-rich boxes in reverse transcription and particle morphogenesis. J. Virol. 2011, 85, 1452-1463.
39. Yu, S.F.; Edelmann, K.; Strong, R.K.; Moebes, A.; Rethwilm, A.; Linial, M.L. The carboxyl terminus of the human foamy virus gag protein contains separable nucleic acid binding and nuclear transport domains. J. Virol. 1996, 70, 8255-8262.
40. Cimarelli, A.; Luban, J. Human immunodeficiency virus type 1 virion density is not determined by nucleocapsid basic residues. J. Virol. 2000, 74, 6734-6740.
41. Stange, A.; Mannigel, I.; Peters, K.; Heinkelein, M.; Stanke, N.; Cartellieri, M.; Gottlinger, H.; Rethwilm, A.; Zentgraf, H.; Lindemann, D. Characterization of prototype foamy virus gag late assembly domain motifs and their role in particle egress and infectivity. J. Virol. 2005, 79, 5466-5476.
42. Patton, G.S.; Morris, S.A.; Chung, W.; Bieniasz, P.D.; McClure, M.O. Identification of domains in gag important for prototypic foamy virus egress. J. Virol. 2005, 79, 6392-6399.
43. Pincetic, A.; Leis, J. The mechanism of budding of retroviruses from cell membranes. Adv. Virol. 2009, 2009, 6239691-6239699.
44. Pornillos, O.; Garrus, J.E.; Sundquist, W.I. Mechanisms of enveloped rna virus budding. Trends Cell. Biol. 2002, 12, 569-579.
45. Morita, E.; Sundquist, W.I. Retrovirus budding. Annu. Rev. Cell Dev. Biol. 2004, 20, 395-425.
46. Thumer, L.; Rethwilm, A.; Holmes, E.C.; Bodem, J. The complete nucleotide sequence of a new world simian foamy virus. Virology 2007, 369, 191-197.
47. Maurer, B.; Flugel, R.M. Genomic organization of the human spumaretrovirus and its relatedness to aids and other retroviruses. AIDS Res. Hum. 1988, 4, 467-473.
48. Matthes, D.; Wiktorowicz, T.; Zahn, J.; Bodem, J.; Stanke, N.; Lindemann, D.; Rethwilm, A. Basic residues in the foamy virus gag protein. J. Virol. 2011, 85, 3986-3995.
49. Fischer, N.; Heinkelein, M.; Lindemann, D.; Enssle, J.; Baum, C.; Werder, E.; Zentgraf, H.; Muller, J.G.; Rethwilm, A. Foamy virus particle formation. J. Virol. 1998, 72, 1610-1615.
50. Lindemann, D.; Goepfert, P.A. The foamy virus envelope glycoproteins. Curr. Top. Microbiol. Immunol. 2003, 277, 111-129.
51. Zhadina, M.; McClure, M.O.; Johnson, M.C.; Bieniasz, P.D. Ubiquitin-dependent virus particle budding without viral protein ubiquitination. Proc. Natl. Acad. Sci. USA 2007, 104, 20031-20036.
52. Liu, Y.; Kim, Y.B.; Lochelt, M. N-terminally myristoylated feline foamy virus gag allows env-independent budding of sub-viral particles. Viruses 2011, 3, 2223-2237.
53. Swiersy, A.; Wiek, C.; Zentgraf, H.; Lindemann, D. Characterization and manipulation of foamy virus membrane interactions. Cell. Microbiol. 2012.
54. Wills, J.W.; Craven, R.C. Form, function, and use of retroviral gag proteins. Aids 1991, 5, 639-654.
55. Dorfman, T.; Luban, J.; Goff, S.P.; Haseltine, W.A.; Gottlinger, H.G. Mapping of functionally important residues of a cysteine-histidine box in the human immunodeficiency virus type 1 nucleocapsid protein. J. Virol. 1993, 67, 6159-6169.
56. Aldovini, A.; Young, R.A. Mutations of rna and protein sequences involved in human immunodeficiency virus type 1 packaging result in production of noninfectious virus. J. Virol. 1990, 64, 1920-1926.
57. D'Souza, V.; Summers, M.F. How retroviruses select their genomes. Nature Rev. Microbiol. 2005, 3, 643-655.
58. Schwartz, M.D.; Fiore, D.; Panganiban, A.T. Distinct functions and requirements for the cys-his boxes of the human immunodeficiency virus type 1 nucleocapsid protein during rna encapsidation and replication. J. Virol. 1997, 71, 9295-9305.
59. Winkler, I.; Bodem, J.; Haas, L.; Zemba, M.; Delius, H.; Flower, R.; Flugel, R.M.; Lochelt, M. Characterization of the genome of feline foamy virus and its proteins shows distinct features different from those of primate spumaviruses. J. Virol. 1997, 71, 6727-6741.
60. Gabus, C.; Ivanyi-Nagy, R.; Depollier, J.; Bucheton, A.; Pelisson, A.; Darlix, J.L. Characterization of a nucleocapsid-like region and of two distinct primer trnalys,2 binding sites in the endogenous retrovirus gypsy. Nucleic Acids Res. 2006, 34, 5764-5777.
61. Schliephake, A.W.; Rethwilm, A. Nuclear localization of foamy virus gag precursor protein. J. Virol. 1994, 68, 4946-4954.
62. Tobaly-Tapiero, J.; Bittoun, P.; Neves, M.; Guillemin, M.C.; Lecellier, C.H.; Puvion-Dutilleul, F.; Gicquel, B.; Zientara, S.; Giron, M.L.; de The, H.; et al. Isolation and characterization of an equine foamy virus. J. Virol. 2000, 74, 4064-4073.
63. Hatton, T.; Zhou, S.; Standring, D.N. Rna-and DNA-binding activities in hepatitis b virus capsid protein: A model for their roles in viral replication. J. Virol. 1992, 66, 5232-5241.
64. Stenbak, C.R.; Linial, M.L. Role of the c terminus of foamy virus gag in rna packaging and pol expression. J. Virol. 2004, 78, 9423-9430.
65. Heinkelein, M.; Leurs, C.; Rammling, M.; Peters, K.; Hanenberg, H.; Rethwilm, A. Pregenomic rna is required for efficient incorporation of pol polyprotein into foamy virus capsids. J. Virol. 2002, 76, 10069-10073.
66. Peters, K.; Wiktorowicz, T.; Heinkelein, M.; Rethwilm, A. Rna and protein requirements for incorporation of the pol protein into foamy virus particles. J. Virol. 2005, 79, 7005-7013.
67. Lee, E.G.; Linial, M.L. The c terminus of foamy retrovirus gag contains determinants for encapsidation of pol protein into virions. J. Virol. 2008, 82, 10803-10810.
68. Lee, E.G.; Linial, M.L. Deletion of a cys-his motif from the alpharetrovirus nucleocapsid domain reveals late domain mutant-like budding defects. Virology 2006, 347, 226-233.
69. Muriaux, D.; Costes, S.; Nagashima, K.; Mirro, J.; Cho, E.; Lockett, S.; Rein, A. Role of murine leukemia virus nucleocapsid protein in virus assembly. J. Virol. 2004, 78, 12378-12385.
70. Hooks, J.J.; Gibbs, C.J., Jr. The foamy viruses. Bacteriol. Rev. 1975, 39, 169-185.
71. Dupont, S.; Sharova, N.; DeHoratius, C.; Virbasius, C.M.; Zhu, X.; Bukrinskaya, A.G.; Stevenson, M.; Green, M.R. A novel nuclear export activity in hiv-1 matrix protein required for viral replication. Nature 1999, 402, 681-685.
72. Nash, M.A.; Meyer, M.K.; Decker, G.L.; Arlinghaus, R.B. A subset of pr65gag is nucleus associated in murine leukemia virus-infected cells. J. Virol. 1993, 67, 1350-1356.
73. Scheifele, L.Z.; Garbitt, R.A.; Rhoads, J.D.; Parent, L.J. Nuclear entry and crm1-dependent nuclear export of the rous sarcoma virus gag polyprotein. Proc. Natl. Acad. Sci. USA 2002, 99, 3944-3949.
74. Beyer, A.R.; Bann, D.V.; Rice, B.; Pultz, I.S.; Kane, M.; Goff, S.P.; Golovkina, T.V.; Parent, L.J. Nucleolar trafficking of the mouse mammary tumor virus gag protein induced by interaction with ribosomal protein l9. J. Virol. 2013, 87, 1069-1082.
75. Kong, X.H.; Yu, H.; Xuan, C.H.; Wang, J.Z.; Chen, Q.M.; Geng, Y.Q. The requirements and mechanism for capsid assembly and budding of bovine foamy virus. Arch. Virol. 2005, 150, 1677-1684.
76. Bodem, J.; Zemba, M.; Flugel, R.M. Nuclear localization of the functional bel 1 transactivator but not of the gag proteins of the feline foamy virus. Virology 1998, 251, 22-27.
77. Mullers, E.; Stirnnagel, K.; Kaulfuss, S.; Lindemann, D. Prototype foamy virus gag nuclear localization: A novel pathway among retroviruses. J. Virol. 2011, 85, 9276-9285.
78. Tobaly-Tapiero, J.; Bittoun, P.; Lehmann-Che, J.; Delelis, O.; Giron, M.L.; de The, H.; Saib, A. Chromatin tethering of incoming foamy virus by the structural gag protein. Traffic 2008, 9, 1717-1727.
79. Stirnnagel, K.; Schupp, D.; Dupont, A.; Kudryavtsev, V.; Reh, J.; Mullers, E.; Lamb, D.C.; Lindemann, D. Differential ph-dependent cellular uptake pathways among foamy viruses elucidated using dual-colored fluorescent particles. Retrovirology 2012, 9, 71.
80. Renault, N.; Tobaly-Tapiero, J.; Paris, J.; Giron, M.L.; Coiffic, A.; Roingeard, P.; Saib, A. A nuclear export signal within the structural gag protein is required for prototype foamy virus replication. Retrovirology 2011, 8, 6.
81. Lo, Y.T.; Tian, T.; Nadeau, P.E.; Park, J.; Mergia, A. The foamy virus genome remains unintegrated in the nuclei of g1/s phase-arrested cells, and integrase is critical for preintegration complex transport into the nucleus. J. Virol. 2010, 84, 2832-2842.
82. Yamashita, M.; Emerman, M. Retroviral infection of non-dividing cells: Old and new perspectives. Virology 2006, 344, 88-93.
83. Heinkelein, M.; Pietschmann, T.; Jarmy, G.; Dressler, M.; Imrich, H.; Thurow, J.; Lindemann, D.; Bock, M.; Moebes, A.; Roy, J.; et al. Efficient intracellular retrotransposition of an exogenous primate retrovirus genome. EMBO J. 2000, 19, 3436-3445.
84. Roy, J.; Rudolph, W.; Juretzek, T.; Gartner, K.; Bock, M.; Herchenroder, O.; Lindemann, D.; Heinkelein, M.; Rethwilm, A. Feline foamy virus genome and replication strategy. J. Virol. 2003, 77, 11324-11331.
85. Kenney, S.P.; Lochmann, T.L.; Schmid, C.L.; Parent, L.J. Intermolecular interactions between retroviral gag proteins in the nucleus. J. Virol. 2008, 82, 683-691.
86. Parent, L.J. New insights into the nuclear localization of retroviral gag proteins. Nucleus 2011, 2, 92-97.
87. Morozov, V.A.; Copeland, T.D.; Nagashima, K.; Gonda, M.A.; Oroszlan, S. Protein composition and morphology of human foamy virus intracellular cores and extracellular particles. Virology 1997, 228, 307-317.
88. Bodem, J.; Schied, T.; Gabriel, R.; Rammling, M.; Rethwilm, A. Foamy virus nuclear rna export is distinct from that of other retroviruses. J. Virol. 2011, 85, 2333-2341.
89. Pinney, J.W.; Dickerson, J.E.; Fu, W.; Sanders-Beer, B.E.; Ptak, R.G.; Robertson, D.L. Hiv-host interactions: A map of viral perturbation of the host system. Aids 2009, 23, 549-554.
90. Ptak, R.G.; Fu, W.; Sanders-Beer, B.E.; Dickerson, J.E.; Pinney, J.W.; Robertson, D.L.; Rozanov, M.N.; Katz, K.S.; Maglott, D.R.; Pruitt, K.D.; et al. Cataloguing the hiv type 1 human protein interaction network. AIDS Res. Hum. Retroviruses 2008, 24, 1497-1502.
91. Sastri, J.; Campbell, E.M. Recent insights into the mechanism and consequences of trim5alpha retroviral restriction. AIDS Res. Hum. Retroviruses 2011, 27, 231-238.
92. Bieniasz, P.D. Intrinsic immunity: A front-line defense against viral attack. Nat. Immunol. 2004, 5, 1109-1115.
93. Yap, M.W.; Lindemann, D.; Stanke, N.; Reh, J.; Westphal, D.; Hanenberg, H.; Ohkura, S.; Stoye, J.P. Restriction of foamy viruses by primate trim5alpha. J. Virol. 2008, 82, 5429-5439.
94. Petit, C.; Giron, M.L.; Tobaly-Tapiero, J.; Bittoun, P.; Real, E.; Jacob, Y.; Tordo, N.; De The, H.; Saib, A. Targeting of incoming retroviral gag to the centrosome involves a direct interaction with the dynein light chain 8. J. Cell Sci. 2003, 116, 3433-3442.
95. Afonso, P.V.; Zamborlini, A.; Saib, A.; Mahieux, R. Centrosome and retroviruses: The dangerous liaisons. Retrovirology 2007, 4, 27.
96. Kutay, U.; Guttinger, S. Leucine-rich nuclear-export signals: Born to be weak. Trends Cell Biol. 2005, 15, 121-124.
97. Yu, S.F.; Lujan, P.; Jackson, D.L.; Emerman, M.; Linial, M.L. The dead-box rna helicase ddx6 is required for efficient encapsidation of a retroviral genome. PLoS Pathog. 2011, 7, e1002303.
98. Erlwein, O.; McClure, M. Gene delivery the key to gene therapy: The case for foamy viruses. Ther. Deliv. 2011, 2, 681-684.
99. Trobridge, G.D.; Horn, P.A.; Beard, B.C.; Kiem, H.P. Large animal models for foamy virus vector gene therapy. Viruses 2012, 4, 3572-3588.